David Goeddel V - 05 Mar 2025 Form 4 Insider Report for Tenaya Therapeutics, Inc. (TNYA)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
07 Mar 2025, 19:14:15 UTC
Prior SEC filing
21 Oct 2024
Next SEC filing
30 May 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ James Evangelista, Attorney-in-Fact

Key filing fact

David Goeddel V filed Form 4 for Tenaya Therapeutics, Inc. (TNYA) on 07 Mar 2025.

Key facts

  • This page summarizes David Goeddel V's Form 4 filing for Tenaya Therapeutics, Inc. (TNYA).
  • 3 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 07 Mar 2025, 19:14.

Change

  • Previous filing in this sequence was filed on 21 Oct 2024.
  • Current net transaction value: +$24,999,999.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TNYA transaction

Common Stock

Purchase

Transaction value
$24,999,999
Shares
+35,714,284
Change %
+263%
Price
$0.7000
Shares after
49,313,559
Date
05 Mar 2025
Ownership
See Footnote
Footnotes
F1, F2, F3
TNYA holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
4,414,720
Date
05 Mar 2025
Ownership
See Footnote
Footnotes
F4
TNYA holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
4,985,570
Date
05 Mar 2025
Ownership
See Footnote
Footnotes
F5

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TNYA transaction Derivative

Series A Warrant (right to buy)

Purchase

Transaction value
Shares
+35,714,284
Change %
Price
Shares after
35,714,284
Date
05 Mar 2025
Ownership
See Footnote
Underlying class
Common Stock
Underlying amount
35,714,284
Exercise price
$0.8000
Footnotes
F1, F2, F3, F6
TNYA transaction Derivative

Series B Warrant (right to buy)

Purchase

Transaction value
Shares
+17,857,142
Change %
Price
Shares after
17,857,142
Date
05 Mar 2025
Ownership
See Footnote
Underlying class
Common Stock
Underlying amount
17,857,142
Exercise price
$0.7000
Footnotes
F1, F2, F3, F7
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 7 footnotes

Footnote F1

Pursuant to an underwritten public offering, The Column Group Opportunity III, LP ("TCG Opportunity III LP") purchased units (the "Units") at a price per Unit of $0.70 per Unit. Each Unit consists of (a) one share of the Issuer's common stock, par value $0.0001 per share (the "Common Stock", and such shares, the "Shares"), (b) one Series A warrant to purchase one share of Common Stock at an exercise price of $0.80 per share which will expire five years from the date of issuance (a "Series A Warrant") and (c) one half of a Series B warrant to purchase a share of Common Stock at an exercise price of $0.70 per share that will expire on June 30, 2026 (a "Series B Warrant").

Footnote F2

The securities are directly held by TCG Opportunity III LP. The Column Group Opportunity III GP, LP ("TCG Opportunity III GP LP") is the general partner of TCG Opportunity III LP and may be deemed to have voting, investment and dispositive power with respect to these securities. TCG Opportunity III GP, LLC ("TCG Opportunity III GP LLC") is the general partner of TCG Opportunity III GP LP and the ultimate general partner of TCG Opportunity III LP and may be deemed to have voting, investment and dispositive power with respect to these securities. The managing members of TCG Opportunity III GP LLC are David Goeddel, a member of the Issuer's board of directors, Peter Svennilson and Tim Kutzkey (collectively, the "Managing Partners").

Footnote F3

(Continued from Footnote 2) The Managing Partners may be deemed to share voting, investment and dispositive power with respect to such securities. TCG Opportunity III GP LP, TCG Opportunity III GP LLC and each of the Managing Partners disclaim beneficial ownership of these securities, except to the extent of their respective pecuniary interest in such securities.

Footnote F4

The securities are directly held by The Column Group III, LP ("TCG III LP"). The Column Group III GP, LP ("TCG III GP") is the general partner of TCG III LP and may be deemed to have voting, investment and dispositive power with respect to these securities. The managing partners of TCG III GP are the Managing Partners. The Managing Partners may be deemed to share voting, investment and dispositive power with respect to such shares. TCG III GP and each of the Managing Partners disclaim beneficial ownership of these shares, except to the extent of their respective pecuniary interest in such shares.

Footnote F5

The securities are directly held by The Column Group III-A, LP ("TCG III-A LP"). TCG III GP is the general partner of TCG III-A LP and may be deemed to have voting, investment and dispositive power with respect to these securities. The managing partners of TCG III GP are the Managing Partners. The Managing Partners may be deemed to share voting, investment and dispositive power with respect to such shares. TCG III GP and each of the Managing Partners disclaim beneficial ownership of these shares, except to the extent of their respective pecuniary interest in such shares.

Footnote F6

Each Series A Warrant is immediately exercisable (subject to certain beneficial ownership limitations).

Footnote F7

Each Series B Warrant is immediately exercisable (subject to certain beneficial ownership limitations).

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .